Respiratory Analysers Market

Respiratory Analysers Market Size, Market Forecast and Outlook By FMI

The respiratory analysers market was valued at USD 4.7 billion in 2025, projected to reach USD 5.45 billion in 2026, and is forecast to expand to USD 23.82 billion by 2036 at a 15.9% CAGR. Expanding hospital critical care infrastructure, growing home care respiratory monitoring adoption, and increasing point-of-care diagnostic demand are creating parallel procurement channels for gas analysis equipment. Paramagnetic oxygen analysers command 47.3% share as their precision measurement capability serves both ventilator management in intensive care and anaesthesia monitoring in surgical settings.

Summary of Respiratory Analysers Market

• Market Snapshot
  • The respiratory analysers market is valued at USD 4.7 billion in 2025 and is projected to reach USD 23.82 billion by 2036.
  • The industry is expected to grow at a 15.9% CAGR from 2026 to 2036, creating an incremental opportunity of USD 18.37 billion.
  • The market is a clinical infrastructure category where measurement precision, connectivity, and deployment across hospital, home care, and point-of-care settings define competitive positioning.
• Demand and Growth Drivers
  • Hospital critical care infrastructure expansion in Asia Pacific and Latin America is generating first-time procurement of respiratory gas analysis equipment for ICU, emergency, and surgical departments.
  • Growing home care respiratory monitoring adoption for COPD and sleep apnoea patients is creating a new distribution channel for compact, connected respiratory analysers.
  • Technology refresh cycles replacing legacy analogue analysers with digital platforms offering wireless connectivity and electronic health record integration are driving replacement procurement in mature markets.
  • Among key countries, China at 21.5%, India at 19.9%, Germany at 18.3%, Brazil at 16.7%, USA at 15.1%, UK at 13.5%, Japan at 11.9%.
• Product and Segment View
  • The market includes paramagnetic oxygen analysers, carbon dioxide analysers, capnography systems, and multi-gas platforms for hospital, home care, and clinical monitoring applications.
  • Paramagnetic Oxygen Analyser leads by Product Name with 47.3% share in 2026.
  • Hospitals leads by Applications with 52.6% share in 2026.
  • Scope includes market scope includes paramagnetic oxygen analysers, infrared carbon dioxide analysers, mainstream and sidestream capnography systems, and multi-gas analysis platforms. Blood gas analysers and pulse oximeters are excluded.
• Geography and Competitive Outlook
  • China and India are the fastest-growing markets at 21.5% and 19.9% CAGR respectively, driven by expanding hospital critical care infrastructure expansion and home respiratory monitoring adoption.
  • USA represents a mature demand base where hospital capital expenditure cycles and home care respiratory monitoring reimbursement sustain analyser procurement.
  • Competition is shaped by measurement precision, connectivity integration, deployment versatility, and clinical workflow compatibility, with key players including Philips Healthcare, ResMed Inc., Medtronic plc, Fisher & Paykel Healthcare, BD (Becton Dickinson and Company), Smiths Medical, Masimo Corporation.
• Analyst Opinion at FMI
  • Sabyasachi Ghosh, Principal Consultant for Healthcare, opines: 'In my analysis, I have observed that respiratory analysers are becoming embedded infrastructure in every tier of healthcare delivery, from ICU bedside monitoring to home care COPD management. Medical device manufacturers maintaining product portfolios concentrated in hospital-grade systems face market share erosion from compact, connected analysers designed for home care and point-of-care deployment. Distributors that fail to offer wireless-enabled, EHR-integrated analyser platforms will lose procurement contracts to competitors matching hospital IT integration requirements.'
• Strategic Implications / Executive Takeaways
  • Medical device manufacturers must develop compact, wireless-enabled respiratory analysers designed for home care and point-of-care deployment to capture the growing market beyond traditional hospital procurement.
  • Hospital capital equipment procurement directors should prioritize respiratory analysers with EHR integration and wireless connectivity to meet clinical workflow digitization requirements.
  • Home care service providers must integrate respiratory gas monitoring into remote patient management platforms to capture the expanding COPD and sleep apnoea monitoring market.

Respiratory Analysers Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 5.45 billion
Industry Value (2036)	USD 23.82 billion
CAGR (2026-2036)	15.9%

Source: Future Market Insights, 2026

The incremental opportunity of USD 18.37 billion over the forecast period reflects hospital infrastructure expansion in Asia Pacific, growing home care respiratory monitoring adoption in ageing societies, and technology upgrades from legacy analysers to digital platforms with wireless connectivity. Hospitals account for 52.6% of application share as intensive care, emergency, and surgical departments maintain the highest density of respiratory gas analysis equipment per patient bed.

China leads at 21.5% CAGR, driven by hospital infrastructure expansion under the Healthy China 2030 initiative and growing critical care bed capacity requiring respiratory gas monitoring equipment. India follows at 19.9%, propelled by the Ayushman Bharat hospital modernization programme and expanding intensive care infrastructure in tier-2 and tier-3 city hospitals. Germany registers 18.3%, anchored by established critical care infrastructure and technology refresh cycles replacing legacy analysers with digital platforms in university hospital networks. Brazil advances at 16.7%, supported by SUS public health system ICU capacity expansion and growing adoption of point-of-care respiratory diagnostics in emergency departments.

The United States expands at 15.1%, driven by hospital capital expenditure cycles for critical care equipment upgrades and growing home care respiratory monitoring reimbursement coverage. The United Kingdom posts 13.5%, driven by NHS ICU capacity expansion programmes and growing home respiratory monitoring adoption for COPD management under integrated care pathways. Japan registers 11.9% growth as the ageing population drives expanding respiratory care infrastructure and home oxygen therapy monitoring equipment procurement.

Respiratory Analysers Market Definition

The respiratory analysers market covers medical and clinical gas measurement instruments designed to analyse oxygen, carbon dioxide, and other respiratory gas concentrations in patient breathing circuits and ambient environments. Products include paramagnetic oxygen analysers, infrared carbon dioxide analysers, capnography systems, and multi-gas analysis platforms deployed in hospitals, home care settings, clinics, and research laboratories.

Respiratory Analysers Market Inclusions

Market scope includes paramagnetic oxygen analysers, infrared carbon dioxide analysers, mainstream and sidestream capnography systems, and multi-gas analysis platforms. Hospital bedside, operating theatre, emergency department, and home care monitoring configurations are covered.

Respiratory Analysers Market Exclusions

Blood gas analysers and pulse oximeters are excluded. The scope omits spirometry systems, peak flow meters, and mechanical ventilators. Laboratory-grade mass spectrometry and chromatography systems for research gas analysis fall outside analytical parameters.

Respiratory Analysers Market Research Methodology

• Primary Research: Analysts engaged with hospital biomedical engineers, respiratory therapy departments, and home care equipment providers to map analyser specification requirements and procurement scheduling.
• Desk Research: Data collection phases aggregated medical device certification registries, hospital capital equipment procurement databases, home care equipment reimbursement schedules, and clinical respiratory monitoring guidelines.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of procurement and installation tracking data, applying region-specific adoption curves to project future deployment velocity.
• Data Validation and Update Cycle: Projections are tested against publicly reported expenditure guidance from leading industry participants and cross-referenced with regulatory filing data.

Rising Trend of Home Care Setting to Generate Growth Opportunities

Over the forecast period, rising healthcare expenditure, emphasis on medical tourism in emerging economies, and the growing need for these medical devices to tap potential are projected to propel the expansion of the global respiratory analysers market and strengthen growth opportunities for the key market players.

The increased demand for therapeutic respiratory devices in home healthcare applications is one important aspect that is projected to generate growth opportunities over the forecast period. In recent years, home healthcare devices have gained recognition and market share.

As the adoption rate of respiratory analyzers keeps increasing, the market for these devices is anticipated to experience profitable opportunities. The respiratory analysers market is also anticipated to develop as a consequence of the increased emphasis on projects by private and governmental organizations to manufacture nanotechnology items that may be used in conjunction with medical equipment.

Manufacturers Focus on Technological Advancements to Lead the Market

To attain a competitive advantage market players are making numerous technological developments, such as the invention of product versions that can be linked to Bluetooth for personalized tracking and analyzers integrated with fuel cell and semiconductor sensor technologies to deliver more precise findings.

Another area of interest for both well-established industry players and other developing players is the development of therapeutic respiratory equipment for home healthcare. For example, Movair, a respiratory therapy company formerly known as International Biophysics Corporation, officially confirmed the USA commercial advent of Luisa in October 2024.

Luisa is a novel ventilator that is intended for use in homes, healthcare facilities, and other institutions as well as portable applications for both invasive and noninvasive airflow.

Respiratory Analysers Market: Drivers

At present, North America is the leading global respiratory analyser market. As per the WHO, chronic obstructive pulmonary disease (COPD) is expected to be the 3rd leading cause of global deaths. According to the National Sleep Foundation, 40 million Americans suffered from insomnia or some other form of chronic sleep disorders.

There are many cases of both COPD and Asthma reported there. While North America leads these statistics, Europe is second in terms of the people complaining of respiratory ailments.The key respiratory analyser market to focus on for long-term growth would be the APAC region.

It is undergoing rapid modernization, with little to no concern for environmental or biological factors, thus giving rise to health issues for its citizens. Increasing focus on medical programs and awareness, both from the government and the private sector all point to a bright future for this market. Hospitals form the largest end users of respiratory analysers and they are also expected to record the highest growth rate.

Respiratory Analysers Market: Restraints

Any equipment which serves a specialised function tends to be expensive and this holds true for the Respiratory Analysers Market as well. The high cost is such a detriment that customers hesitate purchasing modern equipment and prefer using the old, archaic ones.

Even lack of awareness in underdiagnosed, undertreated poorer countries can be a major impediment to growth. Along with this, the installation and usage of such advanced respiratory analysers requires highly skilled professionals, who are in short supply in these nations.

Another issue is the saturation in developed countries due to the oligopolistic market situation. Hence, there are moderate to high barriers for entry for new players seeking to enter this market, thereby limiting competition and customer choice.

Respiratory Analysers Market: Key Regions

The Respiratory Analysers Market can be divided into five key regions viz. North America, Europe, Asia Pacific, Latin America and the Middle East and North Africa. (MENA) North America is the largest market at present and is expected to remain so for the near future.

The fastest growing market for this is unquestionably the Asia- Pacific region. China and India are the fastest growing major economies in the world. Their large populations, increasing government attention towards healthcare, booming medical tourism in them and Southeast Asian nations like Thailand will ensure continued demand for products sold in the respiratory analyser market.

Key players would also be advised to look at Latin America to provide ample growth opportunities in the years to come.

Respiratory Analysers Market: Key Market Players

The main manufacturers in the Respiratory analyser market include globally renowned companies like Smiths Medical (UK), Philips Healthcare (Netherlands), ResMed, Inc. (USA), Covidien plc (Ireland), Masimo Corporation (USA), Fisher and Paykel Healthcare Limited (New Zealand), and CareFusion Corporation (USA).

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.

The research report provides analysis and information according to market segments such as geographies, types and applications.

Scope of the Report

Metric	Value
Quantitative Units	USD 5.45 billion to USD 23.82 billion, at a CAGR of 15.9%
Market Definition	The respiratory analysers market covers medical and clinical gas measurement instruments designed to analyse oxygen, carbon dioxide, and other respiratory gas concentrations in patient breathing circuit.
Segmentation	Product Name: Paramagnetic Oxygen Analyser, Carbon Dioxide Analyser, Others; Applications: Hospitals, Home Care, Clinics, Other Applications
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	China, India, Germany, Brazil, USA, UK, Japan, and 40 plus countries
Key Companies Profiled	Philips Healthcare, ResMed Inc., Medtronic plc, Fisher & Paykel Healthcare, BD (Becton Dickinson and Company), Smiths Medical, Masimo Corporation, Invacare Corporation, GE Healthcare
Forecast Period	2026 to 2036
Approach	Forecasting models apply a bottom-up methodology starting with procurement tracking data and projecting adoption rates using region-specific deployment curves.

Key Segment

By Product Type:

• Paramagnetic Oxygen Analyser
• Carbon Dioxide Analyser
• Others

By Application:

• Hospitals
• Home Care
• Clinics
• Other Applications

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• East Asia
• South Asia and Pacific
• Middle East & Africa

Bibliography

• World Health Organization. (2024). Medical devices for respiratory care: Global procurement guidance. WHO.
• USA Food and Drug Administration. (2024). Respiratory gas analyser premarket notification requirements. FDA.
• International Organization for Standardization. (2024). ISO 80601-2-55: Respiratory gas monitors. ISO.
• European Commission. (2024). Medical Device Regulation 2017/745 respiratory analyser classification guidance. European Commission.
• National Health Service. (2024). NHS Long Term Plan: Home respiratory monitoring equipment procurement guidelines. NHS.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.